These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 32450616)

  • 1. FOXO1 contributes to diabetic cardiomyopathy via inducing imbalanced oxidative metabolism in type 1 diabetes.
    Yan D; Cai Y; Luo J; Liu J; Li X; Ying F; Xie X; Xu A; Ma X; Xia Z
    J Cell Mol Med; 2020 Jul; 24(14):7850-7861. PubMed ID: 32450616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FoxO1 regulates myocardial glucose oxidation rates via transcriptional control of pyruvate dehydrogenase kinase 4 expression.
    Gopal K; Saleme B; Al Batran R; Aburasayn H; Eshreif A; Ho KL; Ma WK; Almutairi M; Eaton F; Gandhi M; Park EA; Sutendra G; Ussher JR
    Am J Physiol Heart Circ Physiol; 2017 Sep; 313(3):H479-H490. PubMed ID: 28687587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin IV attenuates diabetic cardiomyopathy
    Zhang M; Sui W; Xing Y; Cheng J; Cheng C; Xue F; Zhang J; Wang X; Zhang C; Hao P; Zhang Y
    Theranostics; 2021; 11(18):8624-8639. PubMed ID: 34522203
    [No Abstract]   [Full Text] [Related]  

  • 4. KLF5 Is Induced by FOXO1 and Causes Oxidative Stress and Diabetic Cardiomyopathy.
    Kyriazis ID; Hoffman M; Gaignebet L; Lucchese AM; Markopoulou E; Palioura D; Wang C; Bannister TD; Christofidou-Solomidou M; Oka SI; Sadoshima J; Koch WJ; Goldberg IJ; Yang VW; Bialkowska AB; Kararigas G; Drosatos K
    Circ Res; 2021 Feb; 128(3):335-357. PubMed ID: 33539225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXO1 reduces STAT3 activation and causes impaired mitochondrial quality control in diabetic cardiomyopathy.
    Zhou L; Su W; Wang Y; Zhang Y; Xia Z; Lei S
    Diabetes Obes Metab; 2024 Feb; 26(2):732-744. PubMed ID: 37961034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kir6.1 improves cardiac dysfunction in diabetic cardiomyopathy via the AKT-FoxO1 signalling pathway.
    Wang J; Bai J; Duan P; Wang H; Li Y; Zhu Q
    J Cell Mol Med; 2021 Apr; 25(8):3935-3949. PubMed ID: 33547878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,25-Dihydroxyvitamin D attenuates diabetic cardiac autophagy and damage by vitamin D receptor-mediated suppression of FoxO1 translocation.
    Guo X; Lin H; Liu J; Wang D; Li D; Jiang C; Tang Y; Wang J; Zhang T; Li Y; Yao P
    J Nutr Biochem; 2020 Jun; 80():108380. PubMed ID: 32299030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FoxO1 inhibition alleviates type 2 diabetes-related diastolic dysfunction by increasing myocardial pyruvate dehydrogenase activity.
    Gopal K; Al Batran R; Altamimi TR; Greenwell AA; Saed CT; Tabatabaei Dakhili SA; Dimaano MTE; Zhang Y; Eaton F; Sutendra G; Ussher JR
    Cell Rep; 2021 Apr; 35(1):108935. PubMed ID: 33826891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exogenous hydrogen sulfide attenuates the development of diabetic cardiomyopathy via the FoxO1 pathway.
    Ye P; Gu Y; Zhu YR; Chao YL; Kong XQ; Luo J; Ren XM; Zuo GF; Zhang DM; Chen SL
    J Cell Physiol; 2018 Dec; 233(12):9786-9798. PubMed ID: 30078216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exercise enhances cardiac function by improving mitochondrial dysfunction and maintaining energy homoeostasis in the development of diabetic cardiomyopathy.
    Wang SY; Zhu S; Wu J; Zhang M; Xu Y; Xu W; Cui J; Yu B; Cao W; Liu J
    J Mol Med (Berl); 2020 Feb; 98(2):245-261. PubMed ID: 31897508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Akap1 deficiency exacerbates diabetic cardiomyopathy in mice by NDUFS1-mediated mitochondrial dysfunction and apoptosis.
    Qi B; He L; Zhao Y; Zhang L; He Y; Li J; Li C; Zhang B; Huang Q; Xing J; Li F; Li Y; Ji L
    Diabetologia; 2020 May; 63(5):1072-1087. PubMed ID: 32072193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mst1 knockdown alleviates cardiac lipotoxicity and inhibits the development of diabetic cardiomyopathy in db/db mice.
    Xiong Z; Li Y; Zhao Z; Zhang Y; Man W; Lin J; Dong Y; Liu L; Wang B; Wang H; Guo B; Li C; Li F; Wang H; Sun D
    Biochim Biophys Acta Mol Basis Dis; 2020 Aug; 1866(8):165806. PubMed ID: 32320827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Sodium-Glucose Linked Transporter 2 Inhibition With Ertugliflozin on Mitochondrial Function, Energetics, and Metabolic Gene Expression in the Presence and Absence of Diabetes Mellitus in Mice.
    Croteau D; Luptak I; Chambers JM; Hobai I; Panagia M; Pimentel DR; Siwik DA; Qin F; Colucci WS
    J Am Heart Assoc; 2021 Jul; 10(13):e019995. PubMed ID: 34169737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of Foxo1 by insulin resistance promotes cardiac dysfunction and β-myosin heavy chain gene expression.
    Qi Y; Zhu Q; Zhang K; Thomas C; Wu Y; Kumar R; Baker KM; Xu Z; Chen S; Guo S
    Circ Heart Fail; 2015 Jan; 8(1):198-208. PubMed ID: 25477432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eplerenone attenuated cardiac steatosis, apoptosis and diastolic dysfunction in experimental type-II diabetes.
    Ramírez E; Klett-Mingo M; Ares-Carrasco S; Picatoste B; Ferrarini A; Rupérez FJ; Caro-Vadillo A; Barbas C; Egido J; Tuñón J; Lorenzo Ó
    Cardiovasc Diabetol; 2013 Nov; 12():172. PubMed ID: 24261558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXO1-mediated upregulation of pyruvate dehydrogenase kinase-4 (PDK4) decreases glucose oxidation and impairs right ventricular function in pulmonary hypertension: therapeutic benefits of dichloroacetate.
    Piao L; Sidhu VK; Fang YH; Ryan JJ; Parikh KS; Hong Z; Toth PT; Morrow E; Kutty S; Lopaschuk GD; Archer SL
    J Mol Med (Berl); 2013 Mar; 91(3):333-46. PubMed ID: 23247844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial Calpain-1 Disrupts ATP Synthase and Induces Superoxide Generation in Type 1 Diabetic Hearts: A Novel Mechanism Contributing to Diabetic Cardiomyopathy.
    Ni R; Zheng D; Xiong S; Hill DJ; Sun T; Gardiner RB; Fan GC; Lu Y; Abel ED; Greer PA; Peng T
    Diabetes; 2016 Jan; 65(1):255-68. PubMed ID: 26470784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic stress-induced activation of FoxO1 triggers diabetic cardiomyopathy in mice.
    Battiprolu PK; Hojayev B; Jiang N; Wang ZV; Luo X; Iglewski M; Shelton JM; Gerard RD; Rothermel BA; Gillette TG; Lavandero S; Hill JA
    J Clin Invest; 2012 Mar; 122(3):1109-18. PubMed ID: 22326951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac metabolic modulation upon low-carbohydrate low-protein ketogenic diet in diabetic rats studied in vivo using hyperpolarized
    Abdurrachim D; Teo XQ; Woo CC; Ong SY; Salleh NF; Lalic J; Tan RS; Lee PTH
    Diabetes Obes Metab; 2019 Apr; 21(4):949-960. PubMed ID: 30536560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibiting microRNA-144 abates oxidative stress and reduces apoptosis in hearts of streptozotocin-induced diabetic mice.
    Yu M; Liu Y; Zhang B; Shi Y; Cui L; Zhao X
    Cardiovasc Pathol; 2015; 24(6):375-81. PubMed ID: 26164195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.